Bleocel 15mg Injection consists of the active ingredient Bleomycin. It belongs to a group of drugs known as antineoplastic antibiotics. It is commonly used in cancer treatment to slow or stop the growth of cancer cells. It is used to treat lymph node cancers (Hodgkin’s and non-Hodgkin’s lymphoma), head and neck cancer, and cancer in external genitalia. It either be used alone or with radio therapy and chemotherapy treatment. This injection is also beneficial to prevent and treat the fluid accumulation in the lungs that occurs due to cancer. It works by interfering with the production of DNA and RNA in cancer cells. It can cause breaks in the DNA strands and prevent cancer cells from dividing and growing. Bleocel 15mg injection can have side effects, including lung problems, skin reactions, fever, and nausea. In some cases it can also affect kidneys, liver, and heart. Patients receiving it, need to be closely monitored for these side effects. It is typically administered through injection or infusion, either alone or in combination with other chemotherapy drugs. The dosage and frequency of treatment depend on several factors, including the type and stage of cancer, the patient's age and overall health, and the specific treatment plan developed by the oncologist.

Religrast 300mcg injection contains the active constituent filgrastim. It is a white blood cell growth factor (granulocyte-colony stimulating factor) approved by the FDA to decrease the risk of developing febrile neutropenia (occurrence of fever or infection associated with low WBC count) and to reduce the duration of neutropenia (low white blood cell count) in people who have non-myeloid cancer and are receiving chemotherapy drugs. It is also used to increase the number of WBCs and decrease the length of time of fever in people with acute myeloid leukemia. It is also used in people undergoing bone marrow transplants and in people with severe chronic neutropenia (low number of neutrophils in the blood). Religrast 300mcg injection is also used to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the blood). It is also indicated to increase the chance of survival in people exposed to harmful amounts of radiation, which can cause severe damage to the bone marrow. Other uses include in patients with advanced HIV infection, which will help to reduce the risk of infections.

Ondican 4 Injection, also known by the generic name Ondansetron 4 mg Injection, is an antiemetic medication primarily used to prevent and treat nausea and vomiting associated with various medical conditions and treatments. Common Uses 1. Chemotherapy-Induced Nausea and Vomiting (CINV): Ondican 4 is administered to prevent nausea and vomiting caused by chemotherapy. It is typically given 30 minutes before the start of chemotherapy sessions. 2. Radiation Therapy-Induced Nausea and Vomiting: It is used to prevent nausea and vomiting associated with radiation therapy, usually administered 1–2 hours before treatment. 3. Postoperative Nausea and Vomiting (PONV): Ondican 4 helps prevent and treat nausea and vomiting following surgery. It is administered immediately before or within 2 hours after surgery. 4. Other Causes of Nausea and Vomiting: It may also be used to manage nausea and vomiting due to other causes, such as gastroenteritis or certain medical conditions. Mechanism of Action Ondican 4 works by blocking the action of serotonin, a chemical in the body that can trigger nausea and vomiting. By inhibiting serotonin receptors in the brain and gastrointestinal tract, it effectively prevents these symptoms. Administration Ondican 4 Injection is administered intravenously (IV) by a healthcare professional in a hospital or clinic setting. The dosage and timing depend on the specific condition being treated and the patient's medical history. Side Effects Common side effects may include: • Headache • Constipation • Dizziness • Fatigue • Injection site reactions These side effects are generally mild and temporary. However, if they persist or worsen, consult your healthcare provider. Precautions Before receiving Ondican 4, inform your doctor if you have: • Liver disease • Heart problems • Electrolyte imbalances • Blockage in the stomach or intestines Additionally, disclose any other medications you are taking, as interactions may occur. Pregnant or breastfeeding individuals should consult their healthcare provider before use.

Zyrop 5000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Zyrop 5000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Zyrop 5000IU injection.

DARCEPT 40MG INJECTION belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). DARCEPT 40MG INJECTION helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. DARCEPT 40MG INJECTION contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. DARCEPT 40MG INJECTION is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, DARCEPT 40MG INJECTION stimulates the production of this protein in the bone marrow. DARCEPT 40MG INJECTION will be injected by the healthcare provider. Do not self-administer. The most common side effects of DARCEPT 40MG INJECTION are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of DARCEPT 40MG INJECTION do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Zynesp 200 mcg Injection belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). Zynesp 200 mcg Injection helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. Zynesp 200 mcg Injection contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. Zynesp 200 mcg Injection is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, Zynesp 200 mcg Injection stimulates the production of this protein in the bone marrow. Zynesp 200 mcg Injection will be injected by the healthcare provider. Do not self-administer. The most common side effects of Zynesp 200 mcg Injection are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of Zynesp 200 mcg Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to darbepoetin alfa or epoetin alfa, please inform your doctor before taking Zynesp 200 mcg Injection to avoid any complications. Also, mention all the other medications you are taking to affect the way Zynesp 200 mcg Injection works. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be signs that the body has stopped responding to Zynesp 200 mcg Injection .

Fluracil 500mg Injection contains the active ingredient as Fluorouracil. It belongs to a class of drugs called antimetabolites, which interfere with the genetic material (DNA and RNA) synthesis of rapidly dividing cancer cells, leading to their death. It is commonly used to treat breast, colorectal, stomach, esophagus, and pancreatic cancers. It can be administered in different ways, including through injection or as a cream. Like all other anticancer medication, Fluracil 500mg Injection can cause side effects. Common side effects are nausea, vomiting, diarrhea, mouth sores, hair loss, and an increased risk of infection. However, not all patients will experience these side effects, and the severity of the side effects can vary from person to person. No specific foods need to be avoided when receiving Fluracil 500mg Injection, but alcohol, spicy or acidic foods, citrus fruits and juices, and high-fiber foods may worsen some side effects, such as nausea, vomiting, mouth sores, and gastrointestinal problems. Patients should consider avoiding or limiting these foods during treatment. Inform your physician before starting this treatment if you have undergone surgery in the last 30 days or are following a controlled sodium diet.

Erypro safe 4000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Erypro safe 4000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Erypro safe 4000IU injection.

Actorise 40mg Injection – Uses Active Ingredient: Darbepoetin alfa (40 mcg) Primary Uses: Anemia in Chronic Kidney Disease (CKD): Actorise 40 is used to treat anemia in patients whose kidneys are not producing enough erythropoietin—a hormone that helps make red blood cells. Anemia from Chemotherapy: It is also used in cancer patients receiving chemotherapy to treat anemia caused by the suppression of red blood cell production. How It Works: Actorise contains a man-made form of erythropoietin. It signals the bone marrow to produce more red blood cells, helping to restore normal hemoglobin levels and improve energy, oxygen transport, and overall well-being. Administration: Injected under the skin (subcutaneous) or into a vein (intravenous). Must be given by a trained healthcare professional. Storage Instructions: Store in a refrigerator (2°C to 8°C). Do not freeze. Protect from direct light. Precautions & Monitoring: Regular monitoring of hemoglobin and blood pressure is required. Not recommended in patients with uncontrolled high blood pressure. Avoid use if allergic to darbepoetin alfa or similar products.